MedPath

The utility of pre-embolization Aspirin administration for ruptured cerebral aneurysms

Not Applicable
Recruiting
Conditions
Subarachnoid hemorrahge
Registration Number
JPRN-jRCTs031210421
Lead Sponsor
Sumita Kazutaka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
484
Inclusion Criteria

1) Ruptured cerebral aneurysm in the acute phase
2) Scheduled for aneurysm embolization within 72 hours of onset
3) Aged 20 years or older at the time of onset
4) Patients who have obtained written informed consent from the patient or his / her surrogate (spouse, parent, adult child, etc.) to participate in this study.

Exclusion Criteria

1) Pre-stroke activity od daily living is not independent (pre-stroke mRS>3)
2) Dissecting cerebral aneurysm who attempted parent artery occlusion
3) Ruptured previously coil embolized cerebral aneurysm
4) Ruptured infectious cerebral aneurysm or i cerebral aneurysm associated with cerebral arteriovenous malformation, moyamoya disease.
5) Patients who are attempted simultaneously to treat two or more aneurysms
6) Having already taken antiplatelet drugs
7) History of allergies to lactose, aspirin, or salicyclic acid based preparations
8) Cannot perform MRI
9) Patinets who had a contraindications to aspirin
10)Doctor in charge deems inappropriate to participate in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath